Showing 2401-2410 of 4264 results for "".
Therapeutic Focus: Laser and Light Therapy
https://practicaldermatology.com/topics/general-topics/therapeutic-focus-laser-and-light-therapy/21384/New products and pharmacologic developmentsDo Not Be Afraid of an ICD-10 Armageddon
https://practicaldermatology.com/topics/practice-management/do-not-be-afraid-of-an-icd-10-armageddon/21406/Practices that prepare will weather ICD-10 and other requirements.Asset Protection: A Matter Of Degree
https://practicaldermatology.com/topics/practice-management/asset-protection-a-matter-of-degree/21431/How to protect your personal and professional assets.Teledermatology: The Present State of Dermatology's Future
https://practicaldermatology.com/topics/practice-management/teledermatology-the-present-state-of-dermatologys-future/21439/How Much Are You Leaving on the Table?
https://practicaldermatology.com/topics/practice-management/how-much-are-you-leaving-on-the-table/21444/How to improve your after-tax financial efficiency for 2014.Analyzing the New Consensus Statement on Immunotherapy for Melanoma
https://practicaldermatology.com/topics/skin-cancer-photoprotection/analyzing-the-new-consensus-statement-on-immunotherapy-for-melanoma/21506/Keep the Insurance Profit, Reduce Taxes, Protect Assets: Own Your Own Insurance Company
https://practicaldermatology.com/topics/practice-management/keep-the-insurance-profit-reduce-taxes-protect-assets-own-your-own-insurance-company/21516/Here Comes the Sunshine: What you Should Know
https://practicaldermatology.com/topics/practice-management/here-comes-the-sunshine-what-you-should-know/21523/In-Review: Two New Melanoma Agents Approved
https://practicaldermatology.com/topics/skin-cancer-photoprotection/in-review-two-new-melanoma-agents-approved/21534/Utilizing genetic abnormalities, new therapies are carving out new possibilities for melanoma treatment.PV-10: Update on an Emerging Melanoma Therapy
https://practicaldermatology.com/topics/skin-cancer-photoprotection/pv-10-update-on-an-emerging-melanoma-therapy/22971/Last year, Practical Dermatology reviewed data for an intralesional therapy for melanoma. Now a phase III trial appears imminent.